Summit Research Cuts Price Target on Vipshop Holdings (VIPS) Following 2Q15 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Brean Capital Cuts Price Target on Vipshop Holdings (VIPS) Following 2Q15
August 12, 2015 7:22 AM EDTBrean Capital maintained a Buy rating on Vipshop Holdings (NYSE: VIPS), and cut the price target to $25.00 (from $30.00), following the company's 2Q15 earnings results. VIPS reported 2Q15 net revenue of RMB 9.02bn, exceeding consensus estimates of RMB 8.96bn. EPS came in at $0.14, beating Street expectations of $0.12.... More
Notable 52-Week Highs and Lows 8/11: (NVAX) (LPCN) (ADBE) High; (VIPS) (RAX) (ONVO) Low
August 11, 2015 2:57 PM EDT52-Week High:Novavax (Nasdaq: NVAX) $15.01. Novavax gaining Tuesday after it reported Q2 EPS of ($0.08), which was $0.01 better than the analyst estimate of ($0.09). Revenue for the quarter came in at $14 million versus the consensus estimate of $9.9 million. The company also announced positive top-line data from a Phase 2 clinical trial of its RSV F-protein recombinant nanoparticle vaccine candidate (RSV F Vaccine) in older adults... More
Vipshop Holdings (VIPS) Tops Q2 EPS by 2c
August 10, 2015 4:05 PM EDTVipshop Holdings (NYSE: VIPS) reported Q2 EPS of $0.14, $0.02 better than the analyst estimate of $0.12. Revenue for the quarter came in at $1.5 million versus the consensus estimate of $1.45 million.
For earnings history and earnings-related data on Vipshop Holdings (VIPS) click here.
... More